Sopra Steria

We're a global team of 215,000 Resourcers committed to ecological transformation, operating in 56 countries to help cities and industries manage their most critical resources. For over 170 years, we've been developing solutions that treat and distribute water for 111 million people, manage waste for 46 million residents, and produce 44 million MWh of energy annually. Our work spans three main areas - water, waste, and energy - with a focus on recovering and replenishing resources rather than just consuming them. What drives us is the mission to 'resource the world.' This means we're not just providing services; we're helping our customers reduce their carbon footprint, implement circular economy practices, and adapt to climate change. Whether we're optimizing industrial water treatment, designing district heating networks, or transforming waste into energy, we're focused on practical solutions that create real environmental impact. Our people work on the ground every day to make cities more sustainable and industries more efficient - because we believe ecological transformation isn't just necessary, it's an opportunity to build a better future.

Drees & Sommer exists to create a future worth living by transforming how the built environment is designed, constructed, and operated. The construction and real estate industries account for nearly 40% of global carbon emissions, yet traditional approaches remain fragmented, inefficient, and unsustainable. Drees & Sommer tackles this challenge head-on by providing integrated consulting and implementation services that unite vision with reality - delivering projects that are economically viable, ecologically responsible, and digitally enabled. Since 1970, the company has grown from a small Stuttgart engineering office into a global partner-managed consultancy with 6,500 professionals across 70+ cities. Their interdisciplinary teams work on 6,872+ projects worldwide, uniting apparent opposites: tradition and innovation, economy and ecology, analog and digital, efficiency and well-being. As a sustainability pioneer and digitalization driver, Drees & Sommer doesn't just advise clients - they implement solutions that measurably reduce environmental impact while creating lasting value. From carbon-neutral buildings to resilient infrastructure and future-proof industrial facilities, they're proving that sustainable development isn't just necessary - it's the foundation of competitive advantage in a changing world.

In 1980, Sarepta Therapeutics began its journey as AntiVirals Inc., founded by Dwight Weller and Milton Zuker with a vision for advancing antisense chemistry. The company evolved significantly over the decades - transforming through name changes and strategic pivots - from its initial focus on antiviral therapies to becoming a pioneering force in precision genetic medicine for rare diseases. This evolution wasn't just corporate restructuring; it was a response to a critical gap in treating devastating conditions that had long been overlooked by traditional pharmaceutical approaches. Today, Sarepta stands at the forefront of genetic medicine, having launched four FDA-approved therapies including the first-ever gene therapy for Duchenne muscular dystrophy, representing hope for patients who previously had none. Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. With headquarters in Cambridge, Massachusetts, and operations spanning the United States, Ireland, Switzerland, and the United Kingdom, the team is pioneering RNA-targeted therapeutics and gene therapies. Their focus centers on Duchenne muscular dystrophy and limb-girdle muscular dystrophy - debilitating conditions affecting thousands worldwide. Beyond drug development, Sarepta demonstrates deep commitment to patients through programs like SareptAssist, which provides personalized support navigating treatment access, and Route 79, a scholarship program supporting the educational goals of students living with Duchenne. The company's culture is built on values that prioritize patients, urgency, and scientific excellence, driving them daily to transform genetic understanding into life-changing treatments.

Syngenta Group is one of the world's leading agricultural technology and innovation companies, employing more than 56,000 passionate people across more than 90 countries. With Swiss heritage and drawing from a 250-year legacy of scientific excellence, we design the bold breakthroughs growers need to tackle the challenges of modern farming. Our seeds, crop protection, and nutrition products, combined with agronomic solutions and digital services, help farmers provide the world with healthy food, feed, fiber, and fuel while conserving natural resources and protecting the environment. As a global leader in agricultural innovation, we operate through four core business units: Syngenta Crop Protection, Syngenta Seeds, ADAMA, and Syngenta Group China. Together, we represent one of the most geographically and culturally diverse businesses in agriculture, positioned to provide farmers with the best technology and expertise to increase productivity and grow sustainable food. With $611 million in research and development investments over the last decade and recognition as a top ag employer for 9 consecutive years, Syngenta Group continues to drive transformation in how we feed the world's growing population.

With the global population projected to reach 9.7 billion by 2050, farmers face an unprecedented challenge: produce more food while reducing environmental impact and safeguarding natural resources. Syngenta exists to solve this existential problem - empowering farmers with the science-based innovations they need to feed the world while protecting our planet. As a global agriculture leader headquartered in Basel, Switzerland, we employ more than 56,000 people across 90+ countries, drawing from a 250-year legacy of scientific excellence to transform how crops are grown and protected. Our comprehensive portfolio spans crop protection, seeds, biologicals, and digital farming solutions that help farmers grow resilient, healthy crops in the face of climate change, disease, and resource pressures. Through breakthrough innovations like hybrid wheat varieties, CROPWISE™ digital tools, and biological crop protection products, we deliver measurable results: higher yields, lower environmental impact, and regenerative practices that restore soil health. From our MAP centers supporting smallholder farmers in China to our global R&D pipeline investing in the future of agriculture, every decision we make is grounded in our commitment to sustainability and farmer success.

Vonovia stands as Europe's leading private residential real estate company, managing approximately 533,000 residential units across Germany, Sweden, and Austria. Since its establishment in 1998, the organization has grown to become Germany's largest residential landlord, providing homes to over one million people while being listed in the prestigious DAX index. The company maintains a strong commitment to the social market economy, focusing on creating livable neighborhoods and investing in climate-neutral housing infrastructure. With headquarters in Bochum and a workforce exceeding 12,000 employees, Vonovia operates with a clear mission to provide safe, good, and affordable housing solutions. The company actively engages in modernization projects, develops climate-friendly properties, and takes comprehensive responsibility for sustainable urban development. Beyond property management, Vonovia offers housing-related services and maintains a customer-centric approach through digital platforms like the 'Mein Vonovia' app, enabling seamless digital interactions for tenants. The organization balances profitability with social responsibility, making it a cornerstone of residential real estate in central Europe.